FDA Approves New Insomnia Drug

The U.S. Food and Drug Administration said on Wednesday it has approved a first-in-class insomnia drug made by Merck & Co. The FDA approved the drug, suvorexant (Belsomra) in 5, 10, 15 and 20 milligram doses. Belsomra has the potential to cause next-day sleepiness...
Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest